InsiderPresident/CEO and Board Chair
Bobak R. Azamian Insider Trading Activity
Every SEC Form 4 transaction reported by Bobak R. Azamian, sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Is Bobak R. Azamian buying or selling?
Bobak R. Azamian reported 0 open-market buys ($0) and 53 sells ($14.6M) across 53 Form 4 filings at 1 company — a net selling position of $14.6M.
Source: SEC EDGAR Form 4
What stands out
- All 53 of Bobak R. Azamian's Form 4 filings are for one company, Tarsus Pharmaceuticals, Inc. (TARS).
- The most recent Form 4 was accepted on Sep 9, 2026 (39 days ago).
- In the last 12 months: no open-market purchases and 5 sales ($5.2M).
- The largest open-market sale in the last 12 months was $2.4M of Tarsus Pharmaceuticals, Inc. (TARS) on Mar 19, 2026. SEC ↗
Key Statistics (as of Sep 9, 2026)
Total Form 4 filings
53
SEC EDGAR
Companies
1
Buys (0)
$0
Sells (53)
$14.6M
Insider sentiment
Net sellingNet insider flow of $14.6M in net selling, filed between Aug 6, 2021 – Sep 9, 2026.
Companies Bobak R. Azamian files for
| # | Company | Form 4 filings |
|---|---|---|
| 1 | TARSTarsus Pharmaceuticals, Inc. | 53 |
Recent Bobak R. Azamian transactions
| Date | Ticker | Role | Type | Shares | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 9, 2026 | TARS | President/CEO and Board Chair | Sale | 10.0K | $905.6K | SEC ↗ |
| Sep 3, 2026 | TARS | President/CEO and Board Chair | Sale | 10.0K | $800.6K | SEC ↗ |
| Jun 22, 2026 | TARS | President/CEO and Board Chair | Sale | 10.0K | $615.5K | SEC ↗ |
| Mar 19, 2026 | TARS | President/CEO and Board Chair | Sale | 34.6K | $2.4M | SEC ↗ |
| Dec 30, 2025 | TARS | President/CEO and Board Chair | Sale | 6.0K | $495.1K | SEC ↗ |
| Sep 26, 2025 | TARS | President/CEO and Board Chair | Sale | 6.0K | $332.2K | SEC ↗ |
| Aug 13, 2025 | TARS | President/CEO and Board Chair | Sale | 6.0K | $300.0K | SEC ↗ |
| Mar 26, 2025 | TARS | President/CEO and Board Chair | Sale | 6.0K | $300.0K | SEC ↗ |
| Mar 21, 2025 | TARS | President/CEO and Board Chair | Sale | 24.2K | $1.2M | SEC ↗ |
| Dec 29, 2023 | TARS | President/CEO and Board Chair | Sale | 8.0K | $161.8K | SEC ↗ |
| Dec 22, 2023 | TARS | President/CEO and Board Chair | Sale | 40.0K | $810.6K | SEC ↗ |
| Nov 17, 2023 | TARS | President/CEO and Board Chair | Sale | 8.0K | $146.9K | SEC ↗ |
| Oct 20, 2023 | TARS | President/CEO and Board Chair | Sale | 8.0K | $105.9K | SEC ↗ |
| Sep 22, 2023 | TARS | President/CEO and Board Chair | Sale | 8.0K | $137.7K | SEC ↗ |
| Aug 25, 2023 | TARS | President/CEO and Board Chair | Sale | 8.0K | $137.8K | SEC ↗ |
| Jul 21, 2023 | TARS | President/CEO and Board Chair | Sale | 103.9K | $2.1M | SEC ↗ |
| Jul 14, 2023 | TARS | President/CEO and Board Chair | Sale | 9.0K | $156.2K | SEC ↗ |
| Jun 23, 2023 | TARS | President/CEO and Board Chair | Sale | 8.0K | $149.0K | SEC ↗ |
| Jun 16, 2023 | TARS | President/CEO and Board Chair | Sale | 9.0K | $167.2K | SEC ↗ |
| Jun 12, 2023 | TARS | President/CEO and Board Chair | Sale | 3.1K | $62.0K | SEC ↗ |
| May 19, 2023 | TARS | President/CEO and Board Chair | Sale | 8.0K | $127.2K | SEC ↗ |
| May 12, 2023 | TARS | President/CEO and Board Chair | Sale | 9.0K | $151.2K | SEC ↗ |
| May 2, 2023 | TARS | President/CEO and Board Chair | Sale | 10.1K | $152.9K | SEC ↗ |
| Apr 25, 2023 | TARS | President/CEO and Board Chair | Sale | 2.3K | $34.7K | SEC ↗ |
| Apr 21, 2023 | TARS | President/CEO and Board Chair | Sale | 8.0K | $108.8K | SEC ↗ |
Showing the 25 most recent filings of 53. Screen every filing.
Bobak R. Azamian insider trading FAQ
Is Bobak R. Azamian buying or selling?
Across 53 SEC Form 4 filings, Bobak R. Azamian reported 0 open-market purchases totaling $0 and 53 sales totaling $14.6M — a net selling position of $14.6M.
Which companies does Bobak R. Azamian file Form 4s for?
Bobak R. Azamian has reported insider transactions at 1 company, most often Tarsus Pharmaceuticals, Inc. (TARS).
How far back does Bobak R. Azamian's filing history go?
Trabud holds Bobak R. Azamian's SEC Form 4 filings from Aug 6, 2021 – Sep 9, 2026, sourced directly from SEC EDGAR.
Where does Trabud get Bobak R. Azamian's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track Bobak R. Azamian and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener